0       0

31st Annual North American Cystic Fibrosis Conference


S14 - S14: NT: CF Interventions Advancing Through the Clinical Testing Phase


Nov 3, 2017 10:30am ‐ Nov 3, 2017 11:55am

Description

This symposium will review some of the latest trials of CF therapies including both CFTR modulators and anti-inflammatory therapy. Clinical trail data will be presented and put into context with previous work in the field as well as an outlook where the field will be moving towards in the near future.

Learning Objectives:

  1. Define the latest developments in CF therapies.
  2. Express the challenges for clinical trials addressing specific aspects of the disease.
  3. Define how we learn from both successful trials and those that have failed.

Symposium Chair(s):

Symposium Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content